Skip to main content
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Lilly: More weight lost with Zepbound than Wegovy

Summary by BizToc
Eli Lilly and Co. shared in a statement on Tuesday that, according to the latest indirect treatment comparison, "Zepbound (tirzepatide) 10 mg and 15 mg ... delivered greater weight loss than Wegovy HD...

2 Articles

Lean Right

Eli Lilly reported that specific doses of her slimming cane, the Zepbound, provided a weight reduction higher than that obtained with the high-dose version of the competitor Wegovy, developed by rival Novo, according to a recent analysis. Exclusive material for subscribers. To have full access, access the link of the material and register.

·Rio de Janeiro, Brazil
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

BizToc broke the news on Tuesday, September 29, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal